Our Companies
Since 2008, we have founded and built 9 life science companies, a portfolio that is comprised of both established industry leaders and soon-to-be-known successes. With multiple patents, our companies have an aggregate market value of more than $400 million and have provided a 10x return to our early investors. ​And we are only getting started.